PROtein SEquencing (PROSE) Program Announcement
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEF ADVANCED RESEARCH PROJECTS AGCY
Contract Value
Not provided
Codes & Classification
Solicitation Number
DARPA-PA-25-06
NAICS
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Classification Code
AC12
Additional Details
The Defense Advanced Research Projects Agency (DARPA) has issued a solicitation under the PROtein SEquencing (PROSE) Program Announcement (Procurement Identifier: DARPA-PA-25-06), seeking groundbreaking research proposals in the field of protein sequencing. This initiative is designed to catalyze revolutionary advances in scientific understanding, devices, and systems related to protein analysis, explicitly excluding projects that offer only incremental improvements over current technologies.
The scope of the PROSE program centers on the development of innovative approaches that can fundamentally transform protein sequencing capabilities. Proposals must present a comprehensive technical plan, including a detailed scientific and technical justification. Key requirements include an assessment of existing protein read capabilities—such as read elements, measurement instrumentation, and letter calling algorithms—and a clear strategy for adapting these capabilities to meet defined Phase 1 metrics. Proposers are expected to outline anticipated pre-processing steps necessary for preparing purified protein samples for their sequencing approach.
A critical deliverable is the development of an integrated microsystem, capable of achieving advanced Phase 2 metrics. This includes the creation of sophisticated algorithms for letter calling, which must translate raw signal data into specific amino acid sequences with an associated accuracy score. Additionally, proposers must develop an integrated systems model to simulate and evaluate accuracy, throughput, noise, and other relevant characteristics of the microsystem. The proposal should also include a comprehensive list of at least 50 proposer-defined post-translational modifications, non-canonical amino acids, stereoisomers, and other relevant molecular entities ("letters").
Beyond technical development, the program requires a commercialization strategy to support the advanced development and potential market deployment of the protein sequencing technology after the conclusion of the PROSE program. Proposers must also present a plan to meet Controlled Unclassified Information (CUI) requirements, ensuring compliance with federal data protection standards.
DARPA has specified several exclusions to maintain the program’s focus on transformative innovation. Proposals relying on reference sequence availability (such as protein fingerprinting methods), those unable to scale to meet throughput metrics, those incapable of addressing the full chemical complexity of amino acids and their modifications, and those not involving the development of a microsystem (e.g., CMOS, photonic integrated circuits) will not be considered.
This opportunity is classified under NAICS Code 541715, which pertains to Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology), and carries the Product Service Code AC12. The contracting entity is the Defense Advanced Research Projects Agency (DARPA), a federal office, with the primary point of contact listed as the PA Coordinator ([email protected]).
Interested parties should note that the notice is currently inactive, with a post date of August 14, 2025, and a response deadline of August 28, 2025. The solicitation and related materials are available through the official SAM.gov portal (Opportunity ID: db99a1f6f0644043abb73a7a5abbaf05), where 18 attachments provide further details.
Contractors considering this opportunity should evaluate their capabilities against the program’s emphasis on innovative, scalable, and integrated solutions for protein sequencing, as well as their ability to address the technical, regulatory, and commercialization requirements outlined by DARPA. The program’s focus on revolutionary—not evolutionary—advances will remain a constant throughout the contract lifecycle, as will the need for robust microsystem development, algorithmic innovation, and compliance with federal information security standards.
Documents18